<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
	<title>BioToday.com [新着ニュース]</title>
	<description>BioToday.comは医学情報、バイオテクノロジー、バイオベンチャー関連ニュースのデータベースです。</description>
	<link>http://www.biotoday.com/news.cfm</link>
	<managingEditor>biotoday@biotoday.com</managingEditor>
	<copyright>Copyright &#169; 2026 BioToday Ltd. All Rights Reserved.</copyright>
	<lastBuildDate>Sat, 23 May 2026 16:33:22 +0900</lastBuildDate>
	<language>ja</language>
	<docs>http://blogs.law.harvard.edu/tech/rss</docs>
	<item>
		<title>[医学] 寝不足の後にいわばその穴埋めとしてより長く眠ることは早死にを防ぐらしい</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109920&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109920&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 23 May 2026 16:33:22 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109920&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] mRNAワクチンがブンディブギョ株を含む最凶悪なエボラ3種のげっ歯類感染予防</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109919&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109919&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 23 May 2026 16:06:16 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109919&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 3受容体陰性乳癌への第一三共/AstraZenecaのDatroway使用を米国承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109918&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109918&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 23 May 2026 15:13:40 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109918&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] GileadのD型肝炎ウイルス（HDV）薬Hepcludex/ヘプクルデックスを米国も承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109917&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109917&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 23 May 2026 13:58:41 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109917&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] トランスグルタミナーゼ2で切れて光る尿検査薬で腎臓線維化の重症度を識別</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109912&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109912&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 23 May 2026 12:23:18 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109912&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 人工知能（AI）頼りの乳房写真（マンモグラム）検査の10年間の乳癌予想が優越</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109916&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109916&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 23 May 2026 11:46:35 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109916&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 脳の一次運動野の超音波刺激が視床下核β活性を減らしてパーキンソン病を改善</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109915&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109915&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 23 May 2026 10:53:59 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109915&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 肺動脈性肺高血圧症患者のBMP経路がアクチビン伝達阻害薬sotaterceptで減じる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109914&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109914&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 23 May 2026 07:57:25 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109914&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 1型糖尿病の高血糖発生に先立つ膵臓β細胞のオートファジー不調が見つかった</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109913&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109913&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 22 May 2026 16:34:50 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109913&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Moderna/Merckの黒色腫mRNAワクチンは生存の有意改善には至っていない模様</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109911&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109911&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 22 May 2026 11:25:07 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109911&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] BioMarin社のC型ナトリウム利尿ペプチド薬の軟骨低形成症Ph3試験目標達成</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109910&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109910&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 22 May 2026 10:55:43 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109910&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 肥えた成人の体重がLillyの3受容体活性化薬retatrutideで最大3割近く減った</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109909&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109909&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 22 May 2026 10:27:26 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109909&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Biogen/Denaliのパーキンソン病薬BIIB122のPh2b試験LUMAで目当ての効果なし</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109908&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109908&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 22 May 2026 10:06:48 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109908&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 保険請求が拠り所の仮想無作為化試験の治療効果は低く見積もられがち</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109907&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109907&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / BMJ</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 22 May 2026 09:36:53 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109907&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] カルシウムやビタミンD補給の骨折や転倒の目ぼしい予防効果なし</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109906&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109906&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / BMJ</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 21 May 2026 16:55:12 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109906&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] トラネキサム酸静注が帝王切開女性の産後出血を減らした</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109905&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109905&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / BMJ</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 21 May 2026 16:43:04 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109905&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 冠動脈バイパス手術後の抗血小板薬2種併用3か月は1年に劣らず出血率を下げる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109904&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109904&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / BMJ</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 21 May 2026 16:27:34 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109904&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] アルミニウム添加ワクチンの健康への害は見られず</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109903&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109903&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / BMJ</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 21 May 2026 16:01:04 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109903&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] ベンゾジアゼピン等の睡眠/不安薬を使った妊婦の子の神経発達疾患は多くない</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109902&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109902&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / BMJ</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 21 May 2026 15:46:53 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109902&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 頭にあてた磁気での左一次運動野（左M1）刺激で自閉症小児の社交が改善</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109901&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109901&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / BMJ</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 21 May 2026 15:08:12 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109901&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 難儀な親元を幼い頃に去って里親に引き取られた子はより賢く、健やかになる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109900&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109900&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / BMJ</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 21 May 2026 14:46:10 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109900&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Incyte社がGenesis社との人工知能（AI）創薬提携を拡大</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109899&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109899&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 企業間提携</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 21 May 2026 12:14:30 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109899&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Immunovantの甲状腺眼症Ph3試験失敗のFcRn阻害薬batoclimab開発打ち切り</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109898&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109898&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験 || 開発 / 臨床試験 / 中止</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 21 May 2026 11:49:29 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109898&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 便秘薬の後発品を遅らせた損害賠償金9億ドル弱の支払いが武田薬品に命じられた</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109897&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109897&amp;ref=rss</guid>
		<category>ビジネス / トラブル / 訴訟</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 21 May 2026 11:27:48 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109897&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 生後2か月からのPfizerの25価肺炎球菌ワクチンPF07872412接種Ph2試験成績良好</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109896&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109896&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験 || 開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 21 May 2026 11:02:23 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109896&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] ウイルスに依らないDNA核内運搬のEngage Bio社をLillyが最大2億ドル強で買う</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109895&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109895&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 合併/買収</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 21 May 2026 10:44:26 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109895&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] ミトコンドリア外膜がちぎれて作られる小袋が寄生虫の増殖を促す</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109891&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109891&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 21 May 2026 10:01:49 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109891&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] United社のTyvasoが特発性肺線維症に効いた米国/カナダPh3試験論文報告</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109894&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109894&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験 || ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 21 May 2026 09:34:11 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109894&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 救急科の喘鳴幼児への抗生剤アジスロマイシン無効</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109893&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109893&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 21 May 2026 08:37:15 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109893&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 大出血患者の病院到着前輸血をO型全血にしても成分輸血に比べて死亡率下がらず</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109892&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109892&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 21 May 2026 07:57:14 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109892&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 喘息の治療に使われるmontelukastなどのCysLTR1阻害薬が癌治療にも役立ちうる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109890&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109890&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 20 May 2026 16:06:43 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109890&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 曰く付きのTavneosを患者に新たに使うことを止めるようキッセイ薬品が要請</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109889&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109889&amp;ref=rss</guid>
		<category>ビジネス / トラブル / 安全性</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 20 May 2026 14:49:55 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109889&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] UCB社のBimzelxが乾癬性関節炎Ph3試験でAbbVieのSkyriziに10%ほどの差で勝利</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109888&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109888&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 20 May 2026 14:00:54 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109888&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 移植腎臓を助けるHansa社のIgG切断薬imlifidaseの欧州等での権利をSERBが取得</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109887&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109887&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / ライセンス</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 20 May 2026 12:23:51 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109887&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] Apnimed社の睡眠時無呼吸の飲み薬AD109の効果を裏付けたPh3試験論文報告</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109886&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109886&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 20 May 2026 11:15:36 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109886&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] PIK3CA変異血管奇形患者の6割の病変がRelay社のPI3Kα阻害薬で20%以上縮小</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109885&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109885&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 20 May 2026 10:57:38 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109885&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] SanofiのAAT欠損症薬で正常域の働くAAT濃度100%維持〜Wave社も試験結果報告</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109884&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109884&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 20 May 2026 10:14:31 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109884&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] マントル細胞リンパ腫のImbruvica込み初治療での自己幹細胞移植の取り柄示せず</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109883&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109883&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 20 May 2026 08:45:58 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109883&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 117の低〜中所得国（LMIC）への14の感染症ワクチン提供の成果を推定</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109882&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109882&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 20 May 2026 07:12:22 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109882&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] Meiji Seikaのβラクタマーゼ阻害薬nacubactamの取り柄を示したPh3試験論文報告</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109881&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109881&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 19 May 2026 15:12:24 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109881&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] Rocheの抗ST2抗体astegolimabが負け越した慢性閉塞性肺疾患Ph2b/3試験論文</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109880&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109880&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 19 May 2026 13:40:18 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109880&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 落ちた体重をLillyの経口薬FoundayoやGLP-1/GIP薬tirzepatide低用量で維持しうる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109879&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109879&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / Lancet</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 19 May 2026 13:19:13 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109879&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Ipsenの長く効く神経阻害薬のしわ取り効果が6割の患者で半年持続</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109878&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109878&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 19 May 2026 12:11:40 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109878&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] BioMarin社のくる病の一種ENPP1欠損症薬BMN401がPh3試験の目標の1つを逃す</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109877&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109877&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 19 May 2026 10:47:13 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109877&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Merck &amp; CoのTROP2標的抗体sac-TMTがPh3試験で子宮内膜癌患者の生存改善</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109876&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109876&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 19 May 2026 10:29:42 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109876&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 手のつけようがなかった的狙いの治療をRegeneronがParabilisと組んで開発する</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109875&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109875&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 19 May 2026 09:49:08 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109875&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] AstraZenecaの降圧薬Baxfendy/バックスフェンディを米国承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109874&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109874&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 19 May 2026 08:54:14 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109874&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] RegeneronのLAG-3阻害薬fianlimab頼みの黒色腫（メラノーマ）治療Ph3試験失敗</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109873&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109873&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 19 May 2026 08:38:32 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109873&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 中国の太り過ぎ/肥満成人の体重がVincentage社の経口GLP-1薬で12%ほど低下</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109872&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109872&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 19 May 2026 07:24:21 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109872&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 肥満の人の割合は高所得国の多くで落ち着き、中〜低所得国の多くでは上昇</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=109871&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=109871&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 18 May 2026 13:04:20 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A109871&amp;ref=rss</comments>
	</item>
</channel>
</rss>
